NCT02418624View on ClinicalTrials.gov

Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Breast CancerOvarian CancerAdvanced Cancer
Interventions
DRUG

carboplatin, olaparib

2 cycles of carboplatin and olaparib combination therapy followed by olaparib monotherapy.

Trial Locations (1)

1066CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER

NCT02418624 - Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer | Biotech Hunter | Biotech Hunter